Signal transduction of RANK and Toll-like receptor in alveolar bone destruction
RANK和Toll样受体在牙槽骨破坏中的信号转导
基本信息
- 批准号:15390565
- 负责人:
- 金额:$ 9.47万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
LPS is a potent stimulator of bone resorption in inflammatory diseases caused by bacteria. Bacterial lipoprotein/lipopeptides are also pathogen-specific molecular patterns. Toll-like receptor 4 (TLR4) is identified as the signaling receptor for LPS. The complex of TLR6 and TLR2 recognizes diacyl lipopeptide. The signaling cascade of TLR is similar to that of IL-1 receptors, because both TLR and IL-1receptors use MyD88 as a common signaling molecule. Toll-IL-1 receptor domain-containing adapter inducing interferon-γ (TRIF)-mediated signals are also shown to be involved in LPS-induced MyD88-independent pathway. Using MyD88-deficient (MyD88^<-/->) mice and TRIF-deficient (TRIF^<-/->) mice, we examined roles of MyD88 and TRIF in osteoclast differentiation and function. LPS, diacyl lipopeptide (DL) and IL-1 stimulated osteoclastogenesis in co-cultures of osteoblasts and hemopoietic cells obtained from TRIF^<-/-> mice but not MyD88^<-/-> mice. Bone marrow hemopoietic cells from MyD88^<-/-> m … More ice and TRIF^<-/-> mice similarly differentiated into osteoclasts in response to RANKL plus M-CSF. LPS, DL and IL-1 stimulated RANKL mRNA expression in TRIF^<-/-> osteoblasts but not MyD88^<-/-> osteoblasts, suggesting that only MyD88-mediated signal in osteoblasts was important for RANKL expression in response to those factors. This finding was particularly interesting, because both MyD88-dependent and TRIF-dependent pathways are essential for LPS-induced cytokine production in macrophages. Indeed, LPS failed to stimulate IL-6 production in TRIF^<-/-> bone marrow macrophages. But, LPS could stimulate IL-6 production in TRIF^<-/-> osteoblasts. LPS and IL-1 enhanced the survival of TRIF^<-/-> osteoclasts but not MyD88^<-/-> osteoclasts. DL did not support the survival of osteoclasts, because of the lack of TLR6 in osteoclasts. TRIF-related adaptor molecule (TRAM) was shown to be essentially involved in the TRIF-mediated signaling pathway. Interestingly, macrophages expressed both TRIF and TRAM mRNAs, while osteoblasts and osteoclasts expressed only TRIF mRNA. The fact that TRIF-mediated signals are not required for LPS-induced RANKL and IL-6 expression in osteoblasts and for osteoclast survival may be related to the lack of TRAM expression in osteoblasts and osteoclasts. Bone histomorphometry showed that MyD88^<-/-> mice exhibited low turnover osteoporosis with reduced bone resorption and formation. These results suggest that the MyD88-mediated signal is essential for the osteoclastogenesis and function induced by IL-1 and TLR ligands, and that MyD88 is physiologically involved in bone turnover. Less
LPS是由细菌引起的炎症性疾病中骨骼分辨率的潜在刺激剂。细菌脂蛋白/脂肪肽也是病原体特异性分子模式。 Toll样受体4(TLR4)被鉴定为LPS的信号受体。 TLR6和TLR2的复合物识别二酰基脂肽。 TLR的信号传导级联反应与IL-1受体的信号级联相似,因为TLR和IL-1受体使用MyD88作为常见信号分子。 Toll-IL-1受体结构域的辅助转络诱导的干扰素-γ(TRIF)介导的信号也被证明与LPS诱导的MYD88独立途径有关。使用MyD88缺乏(MyD88^< - / - >)小鼠和Trif缺乏症(Trif^< - / - >)小鼠,我们检查了MyD88和Trif在破骨细胞分化和功能中的作用。 LPS,二酰基脂肽(DL)和IL-1在成骨细胞和从TRIF^< - / - >小鼠中获得的成骨细胞和血压细胞的共培养中刺激破骨细胞生成。 Myd88^< - / - > m的骨髓肢体细胞……更多的冰和Trif^< - / - >小鼠类似地分化为破骨细胞,以响应RANKL加M-CSF。 LPS,DL和IL-1在TRIF^< - / - >成骨细胞中刺激了RANKL mRNA表达,但不是MyD88^< - / - >成骨细胞,这表明仅在成骨细胞中仅MyD88介导的信号对于对这些因素的响应而言,对rankl表达很重要。这一发现特别有趣,因为MyD88依赖性和TRIF依赖性途径对于巨噬细胞中LPS诱导的细胞因子产生至关重要。实际上,LP未能刺激Trif^< - / - >骨髓巨噬细胞中的IL-6产生。但是,LP可以刺激Trif^< - / - >成骨细胞中的IL-6产生。 LPS和IL-1增强了Trif^< - / - >破骨细胞的存活,而不是MyD88^< - / - >破骨骨质骨化。由于破骨细胞缺乏TLR6,DL不支持破骨细胞的存活。与TRIF相关的适配器分子(TRAM)证明与TRIF介导的信号通路基本上有关。有趣的是,巨噬细胞同时表达了TRIF和电车mRNA,而成骨细胞和破骨细胞仅表示TRIF mRNA。在成骨细胞中LPS诱导的RANKL和IL-6表达不需要TRIF介导的信号,而对于骨细胞存活,这一事实可能与成骨细胞和破骨细胞中缺乏Tram表达有关。骨骼组形态测定法表明,MyD88^< - / - >小鼠暴露于低周转骨质疏松症,骨骼分辨率和形成减少。这些结果表明,MyD88介导的信号对于由IL-1和TLR配体诱导的破骨细胞生成和功能至关重要,并且MYD88实际上参与了骨转换。较少的
项目成果
期刊论文数量(50)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Itoh K.et al.: "LPS promotes the survival of osteoclasts via toll-like receptor 4, but cytokine production of osteoclasts in response to LPS is different from that of macrophages."Journal of Immunology. 170・7. 3688-3695 (2003)
Itoh K.等人:“LPS通过Toll样受体4促进破骨细胞的存活,但破骨细胞响应LPS的细胞因子产生与巨噬细胞不同。”免疫学杂志170・7。 2003)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Arthritis Research : Methods and Protocols
关节炎研究:方法和方案
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Sato N;et al.;Suda K et al.;Sato N et al.;Takahashi N et al.
- 通讯作者:Takahashi N et al.
Suda K.et al.: "Suppression of osteoprotegerin expression by prostaglandin E_2 is crucially involved in LPS-induced osteoclast formation."Journal of Immunology. 172・4. 2504-2510 (2004)
Suda K.等人:“前列腺素E_2对骨保护素表达的抑制对于LPS诱导的破骨细胞形成至关重要。”免疫学杂志172·4(2004)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
骨吸収と骨形成の共役機構
骨吸收与骨形成的耦合机制
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:清水武彦;韓娟;岡本春憲;新井陽子;前田隆秀;Takahisa TOYAMA et al.;Sato N et al.;中村美どり 他
- 通讯作者:中村美どり 他
MyD88 but not TRIP is essential for osteoclastogenesis induced by lipopolysaccharide, diacyl lipopeptide and IL-1α.
MyD88 而不是 TRIP 对于脂多糖、二酰基脂肽和 IL-1α 诱导的破骨细胞生成至关重要。
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Sato N;et al.
- 通讯作者:et al.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
UDAGAWA Nobuyuki其他文献
UDAGAWA Nobuyuki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('UDAGAWA Nobuyuki', 18)}}的其他基金
Exploration of seeds for development of a new drug targeting Bone-Vascular-Spleen axis
骨-血管-脾轴新药种子开发探索
- 批准号:
25670793 - 财政年份:2013
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Analysis of bone remodeling mechanism between osteoblasts and osteoclasts for the alveolar bone regeneration
成骨细胞与破骨细胞促进牙槽骨再生的骨重塑机制分析
- 批准号:
24390417 - 财政年份:2012
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Basic research on development of new treatment of alveolar bone regeneration
牙槽骨再生新疗法开发的基础研究
- 批准号:
21390498 - 财政年份:2009
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Elucidation of the regulated mechanism of bone metabolism by osteoclastic transcytosis.
阐明破骨细胞转胞吞作用调节骨代谢的机制。
- 批准号:
19390476 - 财政年份:2007
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Establishment of periodontitis treatment method by inhibition of RANK-Toll like receptor signal
抑制RANK-Toll样受体信号治疗牙周炎方法的建立
- 批准号:
17390497 - 财政年份:2005
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Analysis of signal transduction of osteoclast differentiation factor (RANKL) in alveolar bone destruction
破骨细胞分化因子(RANKL)在牙槽骨破坏中的信号转导分析
- 批准号:
13470394 - 财政年份:2001
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The physiological role of osteoclast differentiation factor.
破骨细胞分化因子的生理作用。
- 批准号:
11470393 - 财政年份:1999
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Mechanism of osteoclastogenesis inhibitory action by interleukin 18
白细胞介素18抑制破骨细胞生成的机制
- 批准号:
09671905 - 财政年份:1997
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
异类叶升麻苷通过阻断TLR4二聚体化抑制MyD88/TRIF信号通路减轻重症急性胰腺炎急性肺损伤的作用机制研究
- 批准号:81904041
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
异类叶升麻苷通过阻断TLR4二聚体化抑制MyD88/TRIF信号通路减轻重症急性胰腺炎急性肺损伤的作用机制研究
- 批准号:
- 批准年份:2019
- 资助金额:21 万元
- 项目类别:青年科学基金项目
天然免疫STING/MAVS/TRIF/MyD88信号通路在HBsAg阳性母亲婴儿乙肝疫苗无/弱应答中的作用
- 批准号:81872677
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
针刺干预创伤性脑损伤及其对TLR4/MyD88/TRIF介导的小胶质细胞活化的调控机制研究
- 批准号:81704156
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
MyD88/TRIF共激活模式在RSV感染后激素抗炎效应的作用及机制研究
- 批准号:81300007
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Comparing the role of MyD88 and TRIF in T-cell effector function and the development of heart failure
比较 MyD88 和 TRIF 在 T 细胞效应功能和心力衰竭发展中的作用
- 批准号:
10534476 - 财政年份:2022
- 资助金额:
$ 9.47万 - 项目类别:
Comparing the role of MyD88 and TRIF in T-cell effector function and the development of heart failure
比较 MyD88 和 TRIF 在 T 细胞效应功能和心力衰竭发展中的作用
- 批准号:
10733439 - 财政年份:2022
- 资助金额:
$ 9.47万 - 项目类别:
Analysis of new NLRP3 activation passway by Vibrio cholerae
霍乱弧菌新的NLRP3激活通道分析
- 批准号:
22590396 - 财政年份:2010
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Roles of the MyD88-IRAK pathway and the TRIF-IRF pathway in the host defense against Pseudomonas aeruginosa infection
MyD88-IRAK 通路和 TRIF-IRF 通路在宿主防御铜绿假单胞菌感染中的作用
- 批准号:
185573 - 财政年份:2009
- 资助金额:
$ 9.47万 - 项目类别:
Operating Grants
The recognition mechanism of liposomal LPS
脂质体LPS的识别机制
- 批准号:
19790326 - 财政年份:2007
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Young Scientists (B)